Sort
11,323 grants matching “glioblastoma”
Multivalent Inhibition of Integrin alphaVbeta3
$128,934Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Ferroptosis in drug resistant glioma
$128,727Deanna Marie Tiek · Northwestern University At Chicago · K99 · FY2024 · CA
Ferroptosis in drug resistant glioma
$128,727Deanna Marie Tiek · Northwestern University At Chicago · K99 · FY2023 · CA
Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents
$128,564Tayyaba Hasan · Massachusetts General Hospital · R21 · FY2018 · CA
Administration and neuropathology oversight
$128,208Fred H Hochberg · Massachusetts General Hospital · P01 · FY2015 · CA
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors
$128,113Ningling Kang · Mayo Clinic Rochester · K01 · FY2007 · CA
Administration and neuropathology oversight
$127,742Fred H Hochberg · Massachusetts General Hospital · P01 · FY2016 · CA
Molecular Target Variation Across Environments and at Margins of Glioblastoma
$127,737Daniel J Brat · Emory University · R01 · FY2017 · CA
Multivalent Inhibition of Integrin alphaVbeta3
$127,730Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
$127,680Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Identification of small molecule inhibitors of USP15
$127,680Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Administrative Core
$127,543David M. Ashley · Duke University · U19 · FY2021 · CA
Administrative Core
$127,356Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2022 · CA
Genomics & Bioinformatics
$127,172Cameron Brennan · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Sub-component for Institution # 16-01848 Biostatistics
$127,031Ralph B. Dagostino · Wake Forest University Health Sciences · P01 · FY2021 · CA
AP 3. Chemistry and Drug Discovery
$127,001Gisela P Concepcion · Oregon Health & Science University · U19 · FY2014 · TW
TC-Labeled Cyclic RGDfK Tetramers for Breast Cancer Imaging
$126,860Shuang Liu · Purdue University · R01 · FY2009 · CA
Aging, immunosenescence and glioblastoma
$126,792Derek Alan Wainwright · Loyola University Chicago · K02 · FY2024 · AG
Aging, immunosenescence and glioblastoma
$126,792Derek Alan Wainwright · Loyola University Chicago · K02 · FY2023 · AG
Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy
$126,492Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2020 · CA
Project 3: Single Cell Measures of Intratumor Diversity for Optimal Breast Cancer Therapy
$126,492Kornelia Polyak · Dana-Farber Cancer Inst · U54 · FY2020 · CA
Core 2: Glioblastoma Biorepository Core
$126,370Keith L Ligon · Brigham And Women'S Hospital · P01 · FY2024 · CA
Development of the first topo II inhibitor for brain tumors
$126,249Raymond J Budde · Houston Pharmaceuticals, Inc. · R43 · FY2007 · CA
Intratumor heterogeneity and therapeutic resistance
$126,232Michalina Janiszewska · Dana-Farber Cancer Inst · K99 · FY2016 · CA
Intratumor heterogeneity and therapeutic resistance
$126,232Michalina Janiszewska · Dana-Farber Cancer Inst · K99 · FY2017 · CA